Epitope-specific enhancement of antigen presentation by invariant chain

Journal of Experimental Medicine

Volumn 178, Issue 4, 1993, Pages 1453-1458

  Momburg, Frank ^a   Fuchs, Serge ^a,b   Drexler, Johannes ^a   Busch, Robert ^a   Post, Markus ^a   Hämmerling, Günter J ^a   Adorini, Luciano ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Sandoz Pharma Ltd   (Switzerland)

^c ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHLOROQUINE; DNA; EPITOPE; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; ENDOCYTOSIS; HYBRIDOMA; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; ANTIGEN-PRESENTING CELLS; BREFELDIN A; CELLS, CULTURED; CHLOROQUINE; CYCLOPENTANES; EPITOPES; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMAN; HYBRIDOMAS; RATS; SUPPORT, NON-U.S. GOV'T;

EID: 0027171601     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.178.4.1453     Document Type: Article

References (29)

1. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:707.
2. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S.L. Schmid, V. Quaranta, and P.A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature (Land.). 348:600.
3. Lamb, C.A., J.W. Yewdell, J.R. Bennink, and P. Cresswell. 1991. Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc. Natl. Acad. Sei. USA. 88:5998.
4. Peters, P.J., J.J. Neefjes, V. Oorschot, H.L. Ploegh, and H.J. Geuze. 1991. Segregation of MHC class II molecules from class I molecules in the Golgi complex for transport to lysosomal compartments. Nature (Lond.). 349:669.
5. Roche, P.A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature (Lond.). 345:615.
6. Teyton, L., D. O’Sullivan, P.W. Dickson, V. Lotteau, A. Sette, P. Fink, and P.A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature (Lond.). 348:39.
7. Layet, C., and R.N. Germain. 1991. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex AatAβ dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc Natl. Acad. Sei. USA. 88:2346.
8. Anderson, M., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sei. USA. 89:2282.
9. Stockinger, B., U. Pessara, R.H. Lin, J. Habicht, M. Grez, and N. Koch. 1989. A role of la-associated invariant chains in antigen processing and presentation. Cell. 56:683.
10. Bertolino, P., F. Forquet, S. Pbnt, N. Koch, D. Gerlier, and C. Rabourdin-Combe. 1991. Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells. Int. Immunol. 3:435.
11. Peterson, M., and J. Miller. 1990. Invariant chain influences the immunological recognition of MHC class II molecules. Nature (Lond.). 345:172.
12. Viville, S., J. Neeles, V. Lotteau, A. Dierich, M. Lemeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class-II associated invariant chain. Cell. 72:635.
13. Peterson, M., and Miller, J. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature (Lond.). 357:596.
14. Nadimi, F., J. Moreno, F. Momburg, A. Heuser, S. Fuchs, L. Adorini, and G.J. Hämmerling. 1991. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur. J. Immunol. 21:1255.
15. Adorini, L., J. Moreno, F. Momburg, G.J. Hämmerling, J.-C. Guery, A. Valli, and S. Fuchs. 1991. Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex II-restricted T cells. J. Exp. Med. 174:945.
16. Guery, J.-C., A. Sette, J. Leighton, A. Dragomir, and L. Adorini. 1992. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II binding-peptides. I. Evidence for in vivo MHC blockade preventing T cell activation. J. Exp Med. 175:1345.
17. Allen, P.M., and E.R. Unanue. 1984. Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J. Immunol. 132:1077.
18. Adorini, L., E. Appella, G. Doria, and Z.A. Nagy. 1988. Mechanisms influencing the immunodominance of T cell determinants. J. Exp Med. 168:2091.
19. k molecule. J. Immunol. 141:4124.
20. Busch, R., and J.B. Rothbard. 1990. Detection of pep-tide-MHC class II complexes on the surface of intact cells. J. Immunol. Methods. 134:1.
21. Nowell, J., and V. Quaranta. 1985. Chloroquine affects biosynthesis of la molecules by inhibiting dissociation of invariant (7) chains from α-β dimers in B cells. J. Exp Med. 162:1371.
22. Lippincott-Schwartz, J., L. Yuan, C. Tipper, M. Amherdt, L. Orci, and R.D. Klausner. 1991. Brefeldin A’s effect on en-dosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell. 67:601.
23. Wood, S.A., and W.J. Brown. 1992. The morphology but not the function of endosomes and lysosomes is altered by brefeldin A.J. Cell Biol. 119:273.
24. Adorini, L., S.J. Ullrich, E. Apella, and S. Fuchs. 1990. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T Cells. Nature (Lond.). 346:63.
25. Harding, C., D.S. Collins, J.W. Slot, H.J. Geuze, and E.R. Unanue. 1991. Liposome-encapsuled antigens are processed in lysosomes, recycled, and presented to T cells. Cell. 64:393.
26. Collins, D.S., E.R. Unanue, and C.V. Harding. 1991. Reduction of disulfrde bonds within lysosomes is a key step in antigen processing. J. Immunol. 147:4054.
27. Harding, C., R.W. Roof, P.M. Allen, and E.R. Unanue. 1991. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc Natl Acad. Sci. USA. 88:2740.
28. Sette, A., S. Southwood, D. O’Sullivan, F.C.A. Gaeta, J. Sidney, and H.M. Grey. 1992. Effect of pH on MHC class II-peptide interactions. J. Immunol. 148:844.
29. St. Pierre, Y., and T.H. Watts. 1990. MHC class II-restricted presentation of native protein antigens by B cells is inhibitable by cycloheximide and brefeldin A. J. Immunol. 145:812.